Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,125,438
+$1,294,749 QoQ
Shares Held
28,316
+5.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,099
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Forvis Mazars Wealth Advisors, LLC holds $83,206,945 across 10 Drug Manufacturers - General names. ABBV ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,430 | $50,891,819 | |
| 2 | JNJ |
Johnson & Johnson
|
56,938 | $14,460,543 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
28,316 | $7,125,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
49,526 | $6,364,091 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,031 | $1,442,286 | |
| 6 | PFE |
Pfizer Inc
|
44,567 | $1,073,173 | |
| 7 | AMGN |
Amgen Inc
|
2,240 | $811,148 | |
| 8 | AZN |
Astrazeneca PLC
|
2,202 | $417,543 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,125,438 | 28,316 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,830,689 | 26,809 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $5,980,268 | 26,173 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,081,166 | 26,264 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $4,587,969 | 24,717 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $5,117,526 | 24,425 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,068,345 | 17,267 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $3,364,466 | 17,037 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,314,757 | 25,156 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,034,696 | 16,665 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,393,046 | 15,442 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $2,382,873 | 15,986 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $2,301,188 | 17,080 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,729,005 | 10,849 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,598,807 | 9,893 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,320,760 | 9,841 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,539,717 | 10,053 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,449,749 | 8,943 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,016,312 | 7,506 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $772,025 | 7,157 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $837,928 | 7,439 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,095,402 | 10,122 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,107,319 | 19,667 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $1,514,606 | 17,292 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,488,703 | 15,163 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $700,567 | 9,195 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||